Connect to other sites within the UBM Medica Network
The sodium glucose cotransporter-2 inhibitors are the newest diabetes drugs available. Have you got the basic concepts under your belt? Try these 6 questions and find out.
Less Severe Diabetes Has Better Remission With Surgery
After sleeve gastrectomy, obese patients with type 2 DM who have less severe disease do better than those who have more advanced disease. Surgery should be encouraged sooner rather than later.
Cost of Care Lower with SGLT2 Inhibitor vs DPP-4 Inhibitor
Some of the reasons cited for the observed cost efficiencies: better achievement of A1C and composite quality-of-care goals and fewer treatment failures.
Bariatric Surgery Cuts Diabetes Drugs and Costs
Diabetes and cardiac medications are reduced significantly in obese patients who undergo weight-loss surgery, and so are their costs.
Add-on Therapy with DPP-4 plus SGLT2 Inhibitor Lowered A1c Better than Either Added Alone
In patients with A1c poorly controlled on metformin, dual add-on therapy with saxagliptin plus dapagliflozin brought more to A1c goals than either drug added alone.
Who Should Be Screened for Diabetes?
Until now, the USPSTF has recommended against screening asymptomatic adults for diabetes. A recent draft recommendation shifts focus and suggests intermittent screening for certain high risk adults.
Diabetic vs Idiopathic Gastroparesis: A Symptom ID Quiz
Retching, bloating, abdominal pain, early fullness...which is worse in patients with "diabetic stomach"?
Diabetic Gastroparesis Yields to Blockade of This Receptor
Clue: What do domperidone and metoclopramide have in common?
Man With Newly Diagnosed Type 2 Diabetes: What HbA1c Goal—And How to Get There?
The patient, an active 49-year-old man, had an HbA1c of 8.6 after diabetes was first diagnosed. It’s now 7.6 with metformin and lifestyle measures. Is the current A1c goal adequate, or should you treat more aggressively?
Challenging Case: A Patient With Hypoglycemia and High HbA1c
Hypoglycemia in type 2 diabetes patients can be the result of insulin or sulfonylureas.
Podcast: Bariatric Surgery Bests Medical Therapy Alone in Obese Patients with Diabetes
Bariatric surgery nearly cures type 2 diabetes—at least that’s what results of a new study, presented at the recent ACC meeting, seem to imply.
Podcast: Incretins for Type 2 Diabetes Mellitus (Part 2)
In his second podcast, Dr Louis Kuritzky discusses the classes of incretin-based therapies now available for patients with type 2 diabetes mellitus.
By clicking Accept, you agree to become a member of the UBM Medica Community.